DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹-37 Cr | ₹-278 Cr | ₹-508 Cr | ₹-197 Cr | ₹-808 Cr |
What is the latest Total Non-Current Liabilities ratio of DR REDDYS LABORATORIES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹-37 Cr |
Mar2023 | ₹-278 Cr |
Mar2022 | ₹-508 Cr |
Mar2021 | ₹-197 Cr |
Mar2020 | ₹-808 Cr |
How is Total Non-Current Liabilities of DR REDDYS LABORATORIES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-37 Cr | Negative | |
Mar2023 | ₹-278 Cr | Negative | |
Mar2022 | ₹-508 Cr | Negative | |
Mar2021 | ₹-197 Cr | Negative | |
Mar2020 | ₹-808 Cr | - |
Compare Total Non-Current Liabilities of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹104,133.1 Cr | 0.8% | 1.8% | 13.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹429,361.0 Cr | -1.4% | 1.2% | 46.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,274.0 Cr | -1.4% | 1.8% | 60% | Stock Analytics | |
CIPLA | ₹117,144.0 Cr | -0.3% | -3.3% | 19.1% | Stock Analytics | |
MANKIND PHARMA | ₹106,624.0 Cr | 1.5% | 2.1% | 44.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,554.4 Cr | -1.7% | 1.2% | 53.9% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | 0.8% |
1.8% |
13.5% |
SENSEX | -1% |
3.9% |
16% |
You may also like the below Video Courses